Mirabiologics

<UNKNOWN>, JP · 1 known investors

MiraBiologics develops Neobiologics (multifunctional biopharmaceuticals) using its LassoGraft Technology platform, which grafts cyclic peptides onto proteins to create novel biologically active compounds. The company partners with pharmaceutical companies to apply this technology across diverse therapeutic areas and modalities.